Several cell populations in a TME, including tumor cells and MDSCs, express indole amine-pyrrole 2,3-dioxygenase (IDO), which catalyzes the first biochemical step in the cascade, leading to the conversion of L-tryptophan to kynurenine. The gene discussed is IDO1; the disease is neoplasm.